These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 29984359)

  • 1. Pneumococcal Conjugate Vaccine impact assessment in Bangladesh.
    Baqui AH; McCollum ED; Saha SK; Roy AK; Chowdhury NH; Harrison M; Hanif AAM; Simmons N; Mahmud A; Begum N; Ahmed S; Khan AM; Ahmed ZB; Islam M; Mitra D; Quaiyum A; Chavez MA; Pervaiz F; Miele CH; Schuh HB; Khanam R; Checkley W; Moulton LH; Santosham M
    Gates Open Res; 2018 Apr; 2():21. PubMed ID: 29984359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease among children <2 years old: A prospective population-based study in rural Bangladesh.
    Malaker R; Hasanuzzaman M; Hooda Y; Rahman H; Chandra Das R; Kanon N; Saha S; Tanmoy AM; Ranjan Chakraborty S; Saha S; Islam M; Darmstadt GL; Baqui AH; Sathosam M; El-Arifeen S; Whitney CG; Saha SK
    Vaccine; 2024 Jan; 42(2):255-262. PubMed ID: 38071104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of national introduction of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in Bangladesh: Case-control and time-trend studies.
    Baqui AH; Koffi AK; McCollum ED; Roy AD; Chowdhury NH; Rafiqullah I; Ahmed ZB; Mahmud A; Begum N; Ahmed S; Khanam R; Harrison M; Simmons N; Hossen S; Islam M; Quaiyum A; Checkley W; Santosham M; Moulton LH; Saha SK;
    Vaccine; 2021 Sep; 39(40):5794-5801. PubMed ID: 34465471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term impact of 10-valent pneumococcal conjugate vaccination on invasive pneumococcal disease among children in Finland.
    Rinta-Kokko H; Palmu AA; Auranen K; Nuorti JP; Toropainen M; Siira L; Virtanen MJ; Nohynek H; Jokinen J
    Vaccine; 2018 Apr; 36(15):1934-1940. PubMed ID: 29526371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of 10-valent pneumococcal conjugate vaccine on the incidence of radiologically-confirmed pneumonia and clinically-defined pneumonia in Kenyan children: an interrupted time-series analysis.
    Silaba M; Ooko M; Bottomley C; Sande J; Benamore R; Park K; Ignas J; Maitland K; Mturi N; Makumi A; Otiende M; Kagwanja S; Safari S; Ochola V; Bwanaali T; Bauni E; Gleeson F; Deloria Knoll M; Adetifa I; Marsh K; Williams TN; Kamau T; Sharif S; Levine OS; Hammitt LL; Scott JAG
    Lancet Glob Health; 2019 Mar; 7(3):e337-e346. PubMed ID: 30784634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of the 10-valent pneumococcal conjugate vaccine on pediatric pneumonia confirmed by ultrasound: a matched case-control study.
    Checkley W; Hossen S; McCollum ED; Pervaiz F; Miele CH; Chavez MA; Moulton LH; Simmons N; Roy AD; Chowdhury NH; Ahmed S; Begum N; Quaiyum A; Santosham M; Baqui AH
    Respir Res; 2022 Aug; 23(1):198. PubMed ID: 35915495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of a 10- versus 13-valent pneumococcal conjugate vaccine in Denmark and Sweden.
    Klok RM; Lindkvist RM; Ekelund M; Farkouh RA; Strutton DR
    Clin Ther; 2013 Feb; 35(2):119-34. PubMed ID: 23312274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invasive pneumococcal diseases in children and adults before and after introduction of the 10-valent pneumococcal conjugate vaccine into the Austrian national immunization program.
    Richter L; Schmid D; Kanitz EE; Zwazl I; Pöllabauer E; Jasinska J; Burgmann H; Kundi M; Wiedermann U
    PLoS One; 2019; 14(1):e0210081. PubMed ID: 30629620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of the 10-valent pneumococcal conjugate vaccine against radiographic pneumonia among children in rural Bangladesh: A case-control study.
    McCollum ED; Ahmed S; Roy AD; Chowdhury NH; Schuh HB; Rizvi SJR; Hanif AAM; Khan AM; Mahmud A; Pervaiz F; Harrison M; Reller ME; Simmons N; Quaiyum A; Begum N; Santosham M; Checkley W; Moulton LH; Baqui AH;
    Vaccine; 2020 Sep; 38(42):6508-6516. PubMed ID: 32873404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of invasive Streptococcus pneumoniae serotypes before and 5 years after the introduction of 10-valent pneumococcal conjugate vaccine in Brazil.
    Brandileone MC; Almeida SCG; Minamisava R; Andrade AL
    Vaccine; 2018 May; 36(19):2559-2566. PubMed ID: 29650385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early Declines in Vaccine Type Pneumococcal Carriage in Children Less Than 5 Years Old After Introduction of 10-valent Pneumococcal Conjugate Vaccine in Mozambique.
    Sigaúque B; Moiane B; Massora S; Pimenta F; Verani JR; Mucavele H; Chaúque A; Quintó L; Dos Santos RT; Carvalho MDG; Whitney CG; Lessa FC
    Pediatr Infect Dis J; 2018 Oct; 37(10):1054-1060. PubMed ID: 30216295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of ten-valent pneumococcal conjugate vaccination on invasive pneumococcal disease in Finnish children--a population-based study.
    Jokinen J; Rinta-Kokko H; Siira L; Palmu AA; Virtanen MJ; Nohynek H; Virolainen-Julkunen A; Toropainen M; Nuorti JP
    PLoS One; 2015; 10(3):e0120290. PubMed ID: 25781031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pneumococcal Conjugate Vaccine and Clinically Suspected Invasive Pneumococcal Disease.
    Palmu AA; Kilpi TM; Rinta-Kokko H; Nohynek H; Toropainen M; Nuorti JP; Jokinen J
    Pediatrics; 2015 Jul; 136(1):e22-7. PubMed ID: 26077477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of 10-valent pneumococcal conjugate vaccine against vaccine-type invasive pneumococcal disease in Pakistan.
    Riaz A; Mohiuddin S; Husain S; Yousafzai MT; Sajid M; Kabir F; Rehman NU; Mirza W; Salam B; Nadeem N; Pardhan K; Khan KMA; Raza SJ; Arif F; Iqbal K; Zuberi HK; Whitney CG; Omer SB; Zaidi AKM; Ali A;
    Int J Infect Dis; 2019 Mar; 80():28-33. PubMed ID: 30576865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pneumococcal carriage and antibiotic susceptibility patterns from two cross-sectional colonization surveys among children aged <5 years prior to the introduction of 10-valent pneumococcal conjugate vaccine - Kenya, 2009-2010.
    Kobayashi M; Conklin LM; Bigogo G; Jagero G; Hampton L; Fleming-Dutra KE; Junghae M; Carvalho MD; Pimenta F; Beall B; Taylor T; Laserson KF; Vulule J; Van Beneden C; Kim L; Feikin DR; Whitney CG; Breiman RF
    BMC Infect Dis; 2017 Jan; 17(1):25. PubMed ID: 28056828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Twelve years of pneumococcal conjugate vaccination in the Netherlands: Impact on incidence and clinical outcomes of invasive pneumococcal disease.
    Vestjens SMT; Sanders EAM; Vlaminckx BJ; de Melker HE; van der Ende A; Knol MJ
    Vaccine; 2019 Oct; 37(43):6558-6565. PubMed ID: 31500963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population-based surveillance for invasive pneumococcal disease and pneumonia in infants and young children in Bogotá, Colombia.
    Benavides JA; Ovalle OO; Salvador GR; Gray S; Isaacman D; Rodgers GL
    Vaccine; 2012 Aug; 30(40):5886-92. PubMed ID: 22484295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimating the Clinical and Economic Impact of Switching from the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) to the 10-Valent Pneumococcal Conjugate Vaccine (PCV10) in Italy.
    Ansaldi F; Pugh S; Amicizia D; Di Virgilio R; Trucchi C; Orsi A; Zollo A; Icardi G
    Pathogens; 2020 Jan; 9(2):. PubMed ID: 31979079
    [No Abstract]   [Full Text] [Related]  

  • 19. Early impact of 10-valent pneumococcal conjugate vaccine in childhood pneumonia hospitalizations using primary data from an active population-based surveillance.
    Sgambatti S; Minamisava R; Bierrenbach AL; Toscano CM; Vieira MA; Policena G; Andrade AL
    Vaccine; 2016 Jan; 34(5):663-670. PubMed ID: 26706272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elucidating the impact of the pneumococcal conjugate vaccine programme on pneumonia, sepsis and otitis media hospital admissions in England using a composite control.
    Thorrington D; Andrews N; Stowe J; Miller E; van Hoek AJ
    BMC Med; 2018 Feb; 16(1):13. PubMed ID: 29415741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.